(Q33673305)

28 July 2017

1 reference

title

Pharmacologic treatments for drug and alcohol dependence (English)

1 reference

28 July 2017

1 reference

Kranzler HR

1

1 reference

28 July 2017

Amin H

series ordinal

2

1 reference

28 July 2017

Modesto-Lowe V

series ordinal

3

1 reference

28 July 2017

Oncken C

series ordinal

4

1 reference

28 July 2017

publication date

1 June 1999

1 reference

Psychiatric Clinics of North America

28 July 2017

published in

1 reference

28 July 2017

volume

22

1 reference

28 July 2017

issue

2

1 reference

28 July 2017

page(s)

401-423

1 reference

Alcoholism treatment by disulfiram and community reinforcement therapy.

28 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970084-8

7 January 2021

Buprenorphine treatment of opioid dependence: A review

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970084-8

7 January 2021

How effective is the standard dose of disulfiram? A review of the alcohol-disulfiram reaction in practice

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970084-8

7 January 2021

Differential symptom reduction in depressed cocaine abusers treated with psychotherapy and pharmacotherapy.

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970084-8

7 January 2021

Buprenorphine as a pharmacotherapy for cocaine abuse: a review of the evidence

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970084-8

7 January 2021

A MEDICAL TREATMENT FOR DIACETYLMORPHINE (HEROIN) ADDICTION. A CLINICAL TRIAL WITH METHADONE HYDROCHLORIDE.

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970084-8

7 January 2021

Levo-Alpha Acetyl Methadol (LAAM). Its advantages and drawbacks

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970084-8

7 January 2021

Disulfiram treatment of alcoholism. A Veterans Administration cooperative study

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970084-8

7 January 2021

Fluoxetine is ineffective for treatment of cocaine dependence or concurrent opiate and cocaine dependence: two placebo-controlled double-blind trials.

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970084-8

7 January 2021

A randomized double-blind study of carbamazepine in the treatment of cocaine abuse.

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970084-8

7 January 2021

Nortriptyline and cognitive-behavioral therapy in the treatment of cigarette smoking.

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970084-8

7 January 2021

Bromocriptine for cocaine dependence. A controlled clinical trial.

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970084-8

7 January 2021

Nicotine medications for smoking cessation

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970084-8

7 January 2021

A comparison of sustained-release bupropion and placebo for smoking cessation

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970084-8

7 January 2021

Amantadine in the early treatment of cocaine dependence: a double-blind, placebo-controlled trial.

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970084-8

7 January 2021

Advances in development of medications for alcoholism treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970084-8

7 January 2021

Imipramine treatment of cocaine abuse: possible boundaries of efficacy

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970084-8

7 January 2021

Rapid and ultrarapid opioid detoxification techniques

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970084-8

7 January 2021

Six-month follow-up of naltrexone and psychotherapy for alcohol dependence

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970084-8

7 January 2021

Randomised controlled trial of nasal nicotine spray in smoking cessation.

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970084-8

7 January 2021

Naltrexone and alcohol dependence. Role of subject compliance

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970084-8

7 January 2021

Pharmacotherapy for opioid and cocaine abuse

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970084-8

7 January 2021

Cocaine abuse and dependence

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970084-8

7 January 2021

Implications of recent neuropsychopharmacologic research for understanding the etiology and development of alcoholism

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970084-8

7 January 2021

Recent developments in the pharmacotherapy of substance abuse

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970084-8

7 January 2021

10.1016/S0193-953X(05)70084-8

Identifiers

DOI

1 reference

28 July 2017

1 reference